One case report of epilepsy and rapidly progressive dementia after levofloxacin treatment

Author:

Su Zhan1,Zhang Guimei1,Shen Yanxin1,Li Xiangting1,Wang Zixun1,Zhang Haining1

Affiliation:

1. the First Hospital of Jilin University

Abstract

Abstract Objective: To report a case of seizure and rapidly progressive dementia 20 minutes after intravenous administration of levofloxacin. Case summary: A 56-year-old woman was admitted to hospital with episodic unconsciousness and unresponsiveness. About 4 days ago, she experienced a loss of consciousness, fell to the floor, and yelled for 2 minutes, 20 minutes before the first intravenous dose of levofloxacin. The patient developed symptoms of cognitive impairment after the seizure. Levofloxacin is a synthetic third generation fluoroquinolone used to treat various infectious diseases. Upon admission, the patient was conscious and unresponsive. After 11 days of symptomatic and supportive treatment, the patient was discharged from the hospital with cognition restored to baseline level and no recurrence of seizures 10 months after discharge. Discussion:Epilepsy is a rare adverse reaction to levofloxacin treatment. The patient in this case had infection-related signs before the onset of the disease, and the disease progressed rapidly with fluctuating changes. After ruling out degenerative, infectious, toxic, and autoimmune causes, the patient's symptoms may be attributed to levofloxacin, and this is the first case of seizure and rapidly progressive dementia after levofloxacin injection reported in the literature. Clinicians should be aware that unexplained, rapidly progressing dementia with infection-related signs before onset may be a rare side effect of antibiotics.

Publisher

Research Square Platform LLC

Reference13 articles.

1. Neurotoxicity of antibacterial therapy;Thomas RJ;South Med J,1994

2. Stahlmann R. Safety profile of the quinolones. J Antimicrob Chemother, 1990. 26 Suppl D: p. 31–44.

3. Safety Profile of the Fluoroquinolones;Liu HH;Drug Saf,2010

4. Safety profile of the fluoroquinolones: focus on levofloxacin;Liu HH;Drug Saf,2010

5. Peripheral neuropathy associated with fluoroquinolones;Cohen JS;Ann Pharmacother,2001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3